Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prospective Feasibility Trial of Pharmacokinetic Directed Melphalan for Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Charlotte FM Hughes, Andrew Lin, Maria Bromberg, Sean M. Devlin, Amethyst Saldia, Danielle E Engstler, Danielle M Hanley, Yetunde Aremu, Martin Donach, Elizabeth Hoover, Oscar B Lahoud, Arnab Ghosh, Moneeza Walji, Miguel-Angel Perales, Michael Scordo, Sergio A. Giralt, Gunjan L. Shah, Parastoo B Dahi

Blood (2024) 144 (Supplement 1): 6492.

https://doi.org/10.1182/blood-2024-208310

Published: 2024

Journal Articles

Efficacy of Budesonide Monotherapy for Low Grade GI Gvhd after Post Transplant Cyclophosphamide

Melinda Cook, Grashma Vadakkel, Stephanie Chinapen, Miguel-Angel Perales, Roni Tamari, Esperanza B. Papadopoulos, Doris M. Ponce, Brian C. Shaffer, Andrew Lin

Blood (2024) 144 (Supplement 1): 7356.

https://doi.org/10.1182/blood-2024-200361

Published: 2024

Journal Articles

Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)

Christian Grommes, Anna Piotrowski, Elena Pentsova, Igor Gavrilovic, Jacqueline B Stone, Andrew Lin, Venissala Wongchai, Juli T Madzsar, Rachna Malani, Craig Nolan, Jasmine Francis, Lisa DeAngelis, Lauren Schaff, Ingo K Mellinghoff

Blood (2022) 140 (Supplement 1): 3807–3808.

https://doi.org/10.1182/blood-2022-157001

Published: 2022

Journal Articles

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Blood (2019) 133 (5): 436–445.

https://doi.org/10.1182/blood-2018-09-875732

Published: 2019

Includes: Supplemental data

Journal Articles

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Michael Scordo, MD, Gunjan L. Shah, MD, Elaina V. Preston, PA-C, MPH, Natasia Rodriguez, BSN, RN, Andrew Lin, PharmD, BCOP, Molly Maloy, MS, Brooke Mastrogiacomo, BS, Dean Carlow, MD PhD, Ryan Schofield, MS, Andrea Knezevic, MS, Sean M Devlin, PhD, Heather J. Landau, MD, David J. Chung, MD PhD, Jonathan U. Peled, MD PhD, Marissa L. Buchan, MS, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2018-99-114715

Published: 2018

Journal Articles

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Nicole Pearl, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Larry W Buie, PharmD, BCOP, FASHP, Kevin Robinson, Molly Maloy, MS, Gunjan L. Shah, MD

Blood (2018) 132 (Supplement 1): 4617.

https://doi.org/10.1182/blood-2018-99-119554

Published: 2018

Journal Articles

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Gunjan L. Shah, MD, Heather Landau, MD, Caitlin Sarubbi, A.B, Ryan Schofield, MS, Andrew Lin, PharmD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Sean M. Devlin, PhD, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD

Blood (2017) 130 (Supplement 1): 3296.

https://doi.org/10.1182/blood.V130.Suppl_1.3296.3296

Published: 2017

Journal Articles

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Andrew Lin, PharmD, Patrick Hilden, MS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Roni Tamari, MD, Doris Ponce, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD

Blood (2017) 130 (Supplement 1): 3255.

https://doi.org/10.1182/blood.V130.Suppl_1.3255.3255

Published: 2017

Journal Articles

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD

Blood (2017) 130 (Supplement 1): 2023.

https://doi.org/10.1182/blood.V130.Suppl_1.2023.2023

Published: 2017

Journal Articles

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Poppiti, PharmD, Andrew Lin, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Patrick Hilden, MS, Hugo Castro-Malaspina, MD

Blood (2016) 128 (22): 4623.

https://doi.org/10.1182/blood.V128.22.4623.4623

Published: 2016

Journal Articles

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Beyer, PharmD, Anthony Proli, PharmD, Junting Zheng, Sean Devlin, PhD, Valkal Bhatt, PharmD, Andrew Lin, PharmD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Miguel Perales, MD, Sergio Giralt, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD

Blood (2016) 128 (22): 3392.

https://doi.org/10.1182/blood.V128.22.3392.3392

Published: 2016

Journal Articles

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Tim J Peterson, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Jae H Park, MD

Blood (2015) 126 (23): 1290.

https://doi.org/10.1182/blood.V126.23.1290.1290

Published: 2015

Journal Articles

Outcomes of Pharmacokinetically (PK) Directed Busulfan in Combination with Thiotepa & Cyclophosphamide (TBC) Conditioning with HDT-ASCT in Patients with Primary & Secondary CNS Lymphoma

Valkal Bhatt, PharmD, Michael Scordo, MD, Meier Hsu, MS, Antonio M. Omuro, MD, Lisa DeAngelis, MD, Andrew Lin, PharmD, Matthew J. Matasar, MD MS, Parastoo B. Dahi, MD, Craig H. Moskowitz, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD

Blood (2015) 126 (23): 1994.

https://doi.org/10.1182/blood.V126.23.1994.1994

Published: 2015

Journal Articles

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Andrew Lin, PharmD, BCOP, Qin Zhou, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Dan Douer, MD

Blood (2013) 122 (21): 2644.

https://doi.org/10.1182/blood.V122.21.2644.2644

Published: 2013

Journal Articles

Elevated Complement (C) and IgG Bound Microparticles (MP) in Immune Thrombocytopenic Purpura (ITP) and Hemolytic Anemia (HA).

Wenche Jy, PhD, Lawrence L Horstman, Andrew Lin, Carlos Bidot, Jr., Yeon-Soong Ahn, MD

Blood (2009) 114 (22): 1313.

https://doi.org/10.1182/blood.V114.22.1313.1313

Published: 2009

Journal Articles

A Significant Fraction of ADAMTS13 Activity Is Associated with Activated Platelets and Their Microparticles (PMP): Implication for Regulating ADAMTS13 Activity.

Wenche Jy, PhD, Andrew Lin, Loreta Bidot, BS, Jaehoon Bang, Eugene Ahn, MD, Lawrence L. Horstman, BS, Joaquin J. Jimenez, MD, Carlos J. Bidot, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1066.

https://doi.org/10.1182/blood.V108.11.1066.1066

Published: 2006

Journal Articles

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

Wenche Jy, PhD, Jaehoon Bang, Loreta Bidot, BS, Andrew Lin, Joaquin J. Jimenez, MD, Vincenzo Fontana, MD, Eugene Ahn, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1763.

https://doi.org/10.1182/blood.V108.11.1763.1763

Published: 2006

Journal Articles

Thrombin Generation Profiles Are Qualitatively and Quantitatively Distinct in Microparticles Derived from Red Cells (RMP), Platelets (PMP), and Endothelia (EMP).

Wenche Jy, PhD, Loreta Bidot, BS, Joaquin J. Jimenez, MD, Lawrence L. Horstman, BS, Jaehoon Bang, Andrew Lin, William Zambrano, Jr., Eugene Ahn, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1759.

https://doi.org/10.1182/blood.V108.11.1759.1759

Published: 2006

NARROW

Prospective Feasibility Trial of Pharmacokinetic Directed Melphalan for Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Efficacy of Budesonide Monotherapy for Low Grade GI Gvhd after Post Transplant Cyclophosphamide

Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Outcomes of Pharmacokinetically (PK) Directed Busulfan in Combination with Thiotepa & Cyclophosphamide (TBC) Conditioning with HDT-ASCT in Patients with Primary & Secondary CNS Lymphoma

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Elevated Complement (C) and IgG Bound Microparticles (MP) in Immune Thrombocytopenic Purpura (ITP) and Hemolytic Anemia (HA).

A Significant Fraction of ADAMTS13 Activity Is Associated with Activated Platelets and Their Microparticles (PMP): Implication for Regulating ADAMTS13 Activity.

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

Thrombin Generation Profiles Are Qualitatively and Quantitatively Distinct in Microparticles Derived from Red Cells (RMP), Platelets (PMP), and Endothelia (EMP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only